Clinical Trials Directory

Trials / Unknown

UnknownNCT06107283

Study of the Reduction of the Prescriptions of Benzodiazepines and Related

Study of the Reduction of the Prescriptions of Benzodiazepines and Related After the Discharge of a Service of Follow-up Care and Geriatric Rehabilitation

Status
Unknown
Phase
Study type
Observational
Enrollment
150 (estimated)
Sponsor
University Hospital, Strasbourg, France · Academic / Other
Sex
All
Age
75 Years
Healthy volunteers
Not accepted

Summary

The significant consumption of Benzodiazepines and related drugs in the elderly outside of good practice recommendations is a major issue in the care of the elderly. Adverse effects have been the subject of numerous studies, leading to falls, addictions and even deaths. The general practitioner is often faced with long-term medication intake which is not consistent with a good benefit/risk balance, but stopping or reducing the dosage remains a problem in current practice. The Aftercare and Geriatric Rehabilitation services due to their operation (several weeks of hospitalization) seek to adapt the patient's therapies in order to obtain the most convincing benefit/risk balance possible. A reduction or withdrawal of treatments with Benzodiazepines or related drugs are therefore frequently initiated.

Detailed description

The aim of this research is to quantify among the patients who benefited from a dosage reduction of Benzodiazepines and related drugs during a stay in the Geriatric Care and Aftercare and Rehabilitation department, the number of patients who had an increase of this treatment within 12 weeks following discharge from hospitalization.

Conditions

Timeline

Start date
2023-03-01
Primary completion
2024-08-01
Completion
2024-08-17
First posted
2023-10-30
Last updated
2023-10-30

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT06107283. Inclusion in this directory is not an endorsement.